Featured in this edition of ISpeak Reading Roundup are the top blog posts from May 2019. Discover trending industry topics, developments for the future of pharma, and more for what the pharmaceutical industry was reading last month.
The pharma industry is ever-changing and developing new ways to move forward with science and technology. Pharma 4.0™ incorporates advanced technology to promote innovation and to provide more reliable and secure data. Learn how new technology and operations will propel the industry forward.
Consistency in reliable manufacturing and production systems is an increasingly necessary focus for pharmaceutical professionals in today’s industry. See how the pharma industry can meet new regulatory expectations and redefine good manufacturing practices in the age of complex technologies and treatments.
Biopharmaceutical production is readily adapting to new industry norms and creating opportunities for industry members to venture out of their comfort zone and embrace the future of biopharmaceuticals. Find out how biopharmaceutical production will change and what is expected from industry manufacturers.
This three-part water technology series reviews a redesigned system for increased product performance and cost reduction. Quality control and end-user perspectives of distillation procedures are addressed in this article.
Hear how risk management and FDA guidance can help ease the transition from past manufacturing procedures to complicated and multi-step manufacturing processes. The transition to and incorporation of new pharma tradition will prompt professionals to search for creative ways to overcome obstacles.
Pfizer Asia Pacific Manufacturing Ltd has been honored with the 2024 ISPE Facility of the Year Award (FOYA) Category Award Operations in Project Execution. This prestigious award recognizes the outstanding efforts behind the Pfizer API Facility Extension, commonly referred to as Tuas 2, located in Tuas, Singapore.
As with all aspects of our life sciences industry, understanding how we can best meet the needs of patients with the timely delivery of life saving and sustaining products is of paramount concern. During the years since the global pandemic, the expectations and pressures on the pharmaceutical industry with respect to development, speed to market, quality and sustainability have increased...
At the 2024 ISPE Europe Annual Conference, held in Lisbon, Portugal, 16-18 April, Richard L. Friedman, MS, Deputy Director of the US Food and Drug Administration’s (US FDA) Office of Manufacturing Quality, in...